Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000829847 | SCV000971579 | benign | not provided | 2018-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001807356 | SCV002054564 | benign | Myoclonus, familial, 2 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807353 | SCV002054565 | benign | Cognitive impairment with or without cerebellar ataxia | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807354 | SCV002054566 | benign | Developmental and epileptic encephalopathy, 13 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807355 | SCV002054567 | benign | Seizures, benign familial infantile, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594148 | SCV005087402 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 74% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 69. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000829847 | SCV005228868 | benign | not provided | criteria provided, single submitter | not provided |